Board Member
iBio, Inc. (IBIO)Chief Accounting Officer
Seres Therapeutics, Inc. (MCRB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Arkowitz is recorded as CFO at Pacira BioSciences, Inc. (PCRX), Board Member at iBio, Inc. (IBIO) and Chief Accounting Officer at Seres Therapeutics, Inc. (MCRB). Seres Therapeutics, Inc. reported in an 8-K filed February 26, 2024 that David Arkowitz retired as Executive Vice President and Chief Financial Officer, effective March 15, 2024. The proxy statement of Seres Therapeutics, Inc. reports total compensation of $1,786,650 for David Arkowitz in fiscal 2022, including a base salary of $470,900. Disclosed compensation is on record for 2 fiscal years. David Arkowitz has spoken on 11 earnings calls across 1 company, most recently for Seres Therapeutics, Inc. on March 5, 2024.
“following Mr. Arkowitz's retirement effective as of March 15, 2024 (the "Retirement Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-01-01–present
2021-06-01–present
Start not stated–2024-03-15
Start not stated–2024-03-15
Recorded roles and call appearances connecting this person to public companies.
Chief Accounting Officer
2021-06-01–present
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President, Chief Financial Officer and Head of Business Development | $470,900 | $1,786,650 |
| 2021 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President, Chief Financial Officer and Head of Business Development | $265,417 | $5,226,695 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
